期刊文献+

甲泼尼松龙冲击治疗儿童眼肌型重症肌无力37例 被引量:4

下载PDF
导出
摘要 目的:探讨大剂量甲泼尼松龙(MP)冲击治疗眼肌型重症肌无力(OMG)的疗效。方法:37例确诊为OMG的患儿,给予大剂量MP冲击治疗,冲击结束后予口服泼尼松延续治疗。结果:完全缓解18例、部分缓解16例、无改善3例。结论:MP冲击治疗OMG具有起效快,到达最大疗效时间短、副作用少、激素敏感性高、复发率低等优点。大大增加了患儿和家长的依从性,有利于患儿早日恢复正常的生活和学习。
出处 《实用医学杂志》 CAS 北大核心 2010年第12期2215-2216,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献8

二级参考文献46

  • 1胡学强,江滢.重症肌无力的免疫学和遗传学进展[J].临床内科杂志,2005,22(6):364-366. 被引量:4
  • 2莫雪安.重症肌无力的干细胞治疗现状[J].临床内科杂志,2005,22(6):371-373. 被引量:10
  • 3崔丽英,刘明生.重症肌无力的电生理诊断[J].中国实用内科杂志:临床前沿版,2006,26(2):249-251. 被引量:13
  • 4[7]Anlar B,Ozdirim E,Renda Y,et al.Myasthenia gravis in childhood.Acta Paediatr,1996;85(7):838
  • 5[8]Andrews PI,Massey JM,Sanders DB.Acetylcholine receptor antibodies in juvenile myasthenia gravis.Neurology,1993;43(5):977
  • 6[9]Palmisani MT,Evoli A,Batocchi AP,et al.Myasthenia gravis associated with thymoma.Eur Neurol,1994;34(1):78
  • 7[1]Andrews PI,Massey JM,Howard JF,et al.Race,sex,and puberty influence onset,severity,and outcome in juvenile myasthenia gravis.Neurology,1994;44:1208
  • 8[5]Millichap JG,Dodge PR.Diagnosis and treatment of myasthenia gravis in infancy,childhood,and adolescence.Neurology,1960;10(6):1007
  • 9Spalek P,Schnorrer M,Cibulcik F.Simultaneous occurrence of acute myasthenia gravis and acute polymyositis in 3 patients and in 2 patients also associated with a thymoma.Rozhl Chir,2000,79:468-470.
  • 10Anlar B.Juvenile myasthenia:diagnosis and treatment.Paediatr Drugs,2000,2:161-169.

共引文献62

同被引文献38

  • 1陈志明,庞烈文,陈刚,陆轩,马勤运,陈佶,毛履琰.手术治疗重症肌无力中连接素抗体的临床意义[J].上海医学,2004,27(9):686-688. 被引量:1
  • 2Rostedt Punga A, Ahlqvist K, Bartoccioni E, et al. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes [J]. Clin Neurophysiol, 2006, 117(7): 1434-1443.
  • 3Zhang X, Yang M, Xu J, et al . Clinical and serological study of myasthenia gravis in HuBei Province, China [ J ]. Neurol Neurosurg Psychiatry , 2007,78 (4) : 386-390.
  • 4Suhail H, Vivekanand-hanl S, Singh S, et al. Coexistent of muscle specifc tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient [J]. Neurol India,2010, 58 (4) : 668-669.
  • 5Shigemoto K, Kubo S, Maruyama N, et al. Induction of myasthenia by immunization against muscle-specific kinase [J]. Clin Invest,2006,116 (4): 1016-1024.
  • 6Kim N, Stiegler A L, Cameron T O, et al. Lrp4 is a receptor for Agrin and forms a complex with MuSK[J]. Cell, 2008,135 (2) : 334-342.
  • 7Leite M I, Jacob S, Viegas S, et al. IgG1 antibodies to acetylcholine receptors in ' seronegative' myasthenia gravis [J].Brain, 2008,131 (Pt7), 1940-1952.
  • 8Stiegler A L, Burden S J, Hubbard S R, et al. Crystal Structure of the Agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK [J]. Mol Biol, 2006,364(3 ) : 424-433.
  • 9Pasnoor M, Wolfe G I, Nations S, et al. Clinical findings in MUSK- antibodypositive myasthenia gravis: U.S. experience [J]. Muscle Nerve, 2010, 41(3) :370-374.
  • 10Sanders D B, El-Salem K,Massey J M, et al. Clinical aspects of MuSK antibody positive seronegative MG [J]. Neurology, 2003,60(12) : 1978-1980.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部